Geneos Wealth Management’s JPMorgan BetaBuilders MSCI US REIT ETF BBRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-67
Closed -$6K 2837
2021
Q2
$6K Buy
+67
New +$6.24K ﹤0.01% 2368

Other funds holding BBRE

Geneos Wealth Management's BBRE Position: Q3 2021 in Review

Geneos Wealth Management sold out of JPMorgan BetaBuilders MSCI US REIT ETF (BBRE) in Q3 2021, closing a stake of 67 shares — an estimated $6K sold.

Geneos Wealth Management first reported a position in BBRE in Q2 2021 and held it in 1 quarter. The position peaked at $6K in Q2 2021. 37 funds tracked by Wall St. Rank hold BBRE as of Q3 2021.

  • Geneos Wealth Management reported no remaining JPMorgan BetaBuilders MSCI US REIT ETF position as of Q3 2021 after selling out during the quarter.
  • Geneos Wealth Management sold 67 JPMorgan BetaBuilders MSCI US REIT ETF shares in Q3 2021, an estimated $6K.
  • Geneos Wealth Management first reported a position in JPMorgan BetaBuilders MSCI US REIT ETF in Q2 2021 and held it in 1 quarter.
  • Geneos Wealth Management's JPMorgan BetaBuilders MSCI US REIT ETF position peaked at $6K in Q2 2021.
  • 37 funds tracked by Wall St. Rank held JPMorgan BetaBuilders MSCI US REIT ETF as of Q3 2021.

Based on Geneos Wealth Management's 13F filing for Q3 2021, filed 9 Nov 2021.